News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It?     2/23/2015
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center     2/18/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills     1/30/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD)     1/20/2015
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact     12/29/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada     12/9/2014
Results Of City of Hope Clinical Trial Supports Change To Standard Of Care For HIV Lymphoma     12/5/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
AbbVie (ABBV) Adds Children's AIDS Drugs To Shared Patent Pool     12/1/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights     12/1/2014
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s Rezolsta     11/25/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014

News from Around the Web
Give HIV Drugs To Healthy Gay Men, UK Medical Research Council (MRC) Reveals     2/25/2015
Bill Gates Predicts An HIV Vaccine By 2030     1/30/2015
Birth Control Shot Linked To Increased HIV Risk, University of California, Berkeley (CAL) Study     1/12/2015
The Reason Why Experimental HIV Vaccines Backfire, Emory University Study Suggests     1/7/2015
New Technique For Bioengineering Stem Cells Shows Promise In HIV Resistance, University of California, Davis (UCD) Study     1/2/2015
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
University of Oxford Research Suggests Ability Of HIV To Cause AIDS Is Slowing     12/2/2014
2nd Baby Cured Of HIV Relapses, Lancet Reveals     10/3/2014
Teen’s Organs Rejected Because He’s Gay     8/18/2014
Two Cancer Patients "Cured" Of AIDS After Bone Marrow Transplants, St. Vincent Hospital Study     7/21/2014
Joep Lange, The Physician-Scientist Before Medical Diplomat     7/21/2014
Top AIDS Researchers Killed In Malaysia Airlines Crash, Renowned Scientist Joep Lange Among Dead     7/21/2014
AIDS Epidemic May Be Over By 2030 – United Nations Reveals     7/17/2014
Evidence Reveals The Baby That Was "Cured" Of HIV Wasn't     7/11/2014
Egyptian Military Backtracks On Aids Cure Claims     7/2/2014

Press Releases
Argos Therapeutics, Inc. (ARGS) Director Of Immunology To Present At HIV Vaccines Meeting     3/20/2015
Case Western Reserve University Release: Common Herpes Medication Reduces HIV-1 Levels, Independent of Herpes Infection     3/13/2015
HIV-Positive: Is The Treatment Worse Than The Condition, Asks Journal Of American Physicians And Surgeons     3/9/2015
Gilead (GILD) Announces SVR12 Rates From Phase III Study Evaluating Harvoni For The Treatment Of Chronic Hepatitis C In Patients Co-Infected With HIV     2/27/2015
The Black AIDS Institute In Partnership With Novant Health Brings Health Screenings To Black College Students At CIAA     2/27/2015
Bristol-Myers Squibb (BMY) Release: Study Of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results In Preventing Viral Replication Via Different Mechanism Of Action Than Current Therapies     2/26/2015
Sangamo BioSciences (SGMO) Presents New Clinical Data At CROI 2015 From Trial Of ZFP Therapeutic Designed To Provide Functional Control Of HIV     2/26/2015
Bristol-Myers Squibb (BMY) Release: 48-Week Analysis Of Investigational HIV-1 Attachment Inhibitor Paves Way For Phase III Trial Initiation     2/25/2015
BioTime (BTX) Announces First Patient Treated In Pivotal Clinical Trial Of Renevia™ For HIV-Associated Lipoatrophy     2/24/2015
Enanta Pharmaceuticals, Inc. Announces JAMA Publication Of Results From AbbVie (ABBV)’s Study Of VIEKIRA PAK™ (Ombitasvir, Paritaprevir, Ritonavir Tablets; Dasabuvir Tablets) In Chronic Hepatitis C Patients With HIV-1 Co-Infection (TURQUOISE-I)     2/23/2015
Immune Response BioPharma, Inc. Announces Remune FDA BLA Assignment PDUFA Goal December 22nd 2015     2/16/2015
Anaheim Clinical Trials (ACT) Expands Special Patient Capabilities To Include Patients With Gout Or HIV     2/13/2015
Case Western Reserve University Awarded $3.9 Million for Innovative HIV Research     2/9/2015
ViiV Healthcare Announces $10 Million Initiative To Accelerate Response To HIV/AIDS Among Black Gay And Bisexual Men     2/4/2015
CytoDyn Concludes Phase 2b Study With 98% Success With 4 Weeks Of Monotherapy - Many HIV Patients In Extension Study With Some Approaching 6 Months     2/3/2015

//-->